Highlights
MWC technical excellence helps NZ attract new medicines
A high profile paper has highlighted the growing support the MWC is providing to NZ’s burgeoning clinical trials sector.
read the full story
MWC continues to lead the way in NZ cancer vaccine research
Immune therapy is one of the most exciting and promising areas of cancer research. Around New Zealand, teams of Maurice Wilkins Centre investigators – amongst them postgraduate stu
read the full story
MWC senior leadership team welcomes new appointees
We highlight the recent appointments of three exceptional scientists – Associate Professor Rinki Murphy, Professor Debbie Hay and Dr Nikki Moreland – to the Maurice Wilkins Centre
read the full story
Cancer drug advances to phase II clinical trials
A New Zealand cancer drug developed by two Maurice Wilkins Centre investigators has reached the second phase of clinical trials with patients.
read the full story
Partnerships boost business: MWC supports Auckland Clinical Studies (2013)
The Maurice Wilkins Centre provides world-class support for medical trials provider Auckland Clinical Studies, helping to cement New Zealand’s growing reputation as a good place to
read the full story
New chemistry transforms cancer vaccine (2013)
A new kind of chemistry that dramatically simplifies the manufacture of cancer vaccines was created this year by Honours student Tom Wright.
read the full story
Stepping up the fight: The Tuberculosis Flagship (2013)
The Maurice Wilkins Centre is behind the launch of a national research network of ‘serious intellectual muscle’ that aims to speed up action against tuberculosis.
read the full story
New Zealand TB drug candidate selected (2012)
In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidate by international non-profit drug developer the Global
read the full story
A licence to manufacture medicines (2012)
A licence to manufacture medicines has been granted to a University of Auckland facility that will produce the active ingredients of cancer vaccines to be tested in humans. The fac
read the full story
Dissecting drug side effects offers hope (2011)
Researchers from the Maurice Wilkins Centre have discovered how a common class of medicines causes diabetes-like symptoms, and their work suggests a promising way of managing these
read the full story
Joining forces against infectious disease (2010)
The 2010 Superbugs Symposium convened by the Maurice Wilkins Centre brought together more than 350 medical professionals and scientists fighting infectious disease.
read the full story
Drug selection a milestone for spin-out (2010)
In 2010 Maurice Wilkins Centre investigators Professors Bill Denny and Peter Shepherd selected a new anticancer drug candidate for clinical development, triggering US $4.5 million
read the full story
Help with difficult diagnoses (2009)
Maurice Wilkins Centre technology is helping Auckland Hospital with difficult diagnoses.
read the full story
Creating connections between drug discovery and business (2009)
The Maurice Wilkins Centre hosted the New Zealand Drug Discovery Symposium in September 2009, bringing together more than 450 delegates from science, medicine, business, and ventur
read the full story
Cancer stealth drug enters clinical development (2010)
The first of an exciting new class of anticancer drugs will proceed to clinical development under an international deal announced in early 2011.
read the full story
New Zealand patients trial local cancer drug (2012)
Cancer patients in Auckland, Waikato and the United States are participating in the first clinical trial of an exciting new drug invented in New Zealand.
read the full story
New drug targets treatment-resistant cancer (2011)
A new drug targeting an important group of cancer cells attracted international funding in 2011 and will soon enter clinical trials.
read the full story